Metabolic risk with second-generation antipsychotic treatment: a double-blind randomized 8-week trial of risperidone and olanzapine (Q46528205)
Jump to navigation
Jump to search
scientific article published in April 2008
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Metabolic risk with second-generation antipsychotic treatment: a double-blind randomized 8-week trial of risperidone and olanzapine |
scientific article published in April 2008 |
Statements
1 reference
Metabolic risk with second-generation antipsychotic treatment: a double-blind randomized 8-week trial of risperidone and olanzapine (English)
1 reference
Robert R Conley
1 reference
Deanna L Kelly
1 reference
Raymond C Love
1 reference
John A Morrison
1 reference
Robert P McMahon
1 reference
1 April 2008
1 reference
20
1 reference
2
1 reference
71-78
1 reference